House Pediatric Bill May Add Generic Exclusivity Provisions In Committee
Executive Summary
The House Commerce Committee is considering adding language to the pediatric exclusivity bill to cut off an effort by Bristol-Myers Squibb to block generic versions of Glucophage and BuSpar.